Risk assessment of disease recurrence in early breast cancer: A serum metabolomic study focused on elderly patients
Background: We previously showed that metabolomics predicts relapse in early breast cancer (eBC) patients, unselected by age. This study aims to identify a “metabolic signature” that differentiates eBC from advanced breast cancer (aBC) patients, and to investigate its potential prognostic role in an...
Main Authors: | Emanuela Risi, Camilla Lisanti, Alessia Vignoli, Chiara Biagioni, Agnese Paderi, Silvia Cappadona, Francesca Del Monte, Erica Moretti, Giuseppina Sanna, Luca Livraghi, Luca Malorni, Matteo Benelli, Fabio Puglisi, Claudio Luchinat, Leonardo Tenori, Laura Biganzoli |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-01-01
|
Series: | Translational Oncology |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1936523322002443 |
Similar Items
-
Precision Oncology via NMR-Based Metabolomics: A Review on Breast Cancer
by: Alessia Vignoli, et al.
Published: (2021-04-01) -
NMR-based metabolomics in Alzheimer’s disease research: a review
by: Alessia Vignoli, et al.
Published: (2023-11-01) -
Metabolomics Fingerprint Predicts Risk of Death in Dilated Cardiomyopathy and Heart Failure
by: Alessia Vignoli, et al.
Published: (2022-04-01) -
A Serum Metabolomics Classifier Derived from Elderly Patients with Metastatic Colorectal Cancer Predicts Relapse in the Adjuvant Setting
by: Samantha Di Donato, et al.
Published: (2021-06-01) -
PIK3CA co-occurring mutations and copy-number gain in hormone receptor positive and HER2 negative breast cancer
by: Ilenia Migliaccio, et al.
Published: (2022-02-01)